Prospects for the future of child health through research

Ralph D Feigin1

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, USA. rfeigin@bcm.tmc.edu

JAMA
|September 22, 2005
PubMed

Insights

Genomic and environmental research will accelerate child health advancements. New technologies and long-term studies are crucial for preventing and treating childhood disorders, addressing societal issues, and navigating ethical considerations.

Area of Science:

  • Pediatrics
  • Genomics
  • Environmental Health

Background:

  • Childhood morbidity and mortality remain significant global health challenges.
  • The post-genomic era offers unprecedented opportunities for medical research and discovery.
  • Understanding gene-environment interactions is key to addressing complex pediatric diseases.

Purpose of the Study:

  • To review pressing causes of child morbidity and mortality.
  • To discuss the application of novel technologies in pediatric research.
  • To predict the impact of future discoveries on childhood disease outcomes.

Main Methods:

  • Review of current literature on childhood disorders.
  • Exploration of emerging technologies like genomics, proteomics, and nanosystems.
  • Analysis of the influence of environmental factors on genetic predispositions.

Main Results:

  • Genomics, proteomics, and nanosystems will enhance prevention and treatment of childhood disorders.
  • Integration of environmental and genetic data will improve disease understanding.
  • New discoveries hold promise for ameliorating the consequences of childhood diseases.

Conclusions:

  • Accelerated research in the post-genomic era will significantly improve child health.
  • Prospective long-term studies are essential for tackling preventable, societally rooted problems.
  • Physician-scientists must address the ethical, political, and social implications of medical advances.

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K